Cellectis SA expected to post a loss of 21 cents a share - Earnings Preview
Cellectis SA
ALCLS,
ALCLS is expected to show a rise in quarterly revenue when it reports results on August 4 for the period ending June 30 2025
The Paris Ile-de-france-based company is expected to report a 18.1% increase in revenue to $11.226 million from $9.5 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for Cellectis SA is for a loss of 21 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Cellectis SA is $5.00, about 49.8% above its last closing price of $2.51
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | -0.17 | -0.19 | -0.18 | Beat | 6.4 |
Dec. 31 2025 | -0.18 | 0.08 | Beat | 143.2 | |
Sep. 30 2024 | -0.20 | -0.21 | -0.23 | Missed | -7.9 |
Jun. 30 2024 | -0.32 | -0.30 | -0.28 | Beat | 7.8 |
Mar. 31 2024 | -0.35 | -0.33 | 0.08 | Beat | 124.2 |
Dec. 31 2023 | 0.27 | -0.22 | -0.70 | Missed | -223.5 |
Sep. 30 2023 | -0.36 | -0.42 | -0.31 | Beat | 25.4 |
Jun. 30 2023 | -0.41 | -0.45 | -0.19 | Beat | 58.2 |
This summary was machine generated August 1 at 14:59 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)